Journal Article
. 2017 Nov;48(1).
doi: 10.1002/jmri.25909.

Diffusion-weighted MRI characteristics associated with prognostic pathological factors and recurrence risk in invasive ER+/HER2- breast cancers

Nita Amornsiripanitch 1 Vicky T Nguyen 1 Habib Rahbar 1 Daniel S Hippe 1 Vijayakrishna K Gadi 2 Mara H Rendi 3 Savannah C Partridge 1 
Affiliations
  • PMID: 29178616
  •     35 References
  •     8 citations

Abstract

Background: Hormone receptor-positive breast cancer is the most common subtype; better tools to identify which patients in this group would derive clear benefit from chemotherapy are needed.

Purpose: To evaluate the prognostic potential of diffusion-weighted MRI (DWI) by investigating associations with pathologic biomarkers and a genomic assay for 10-year recurrence risk.

Study Type: Retrospective.

Subjects: In all, 107 consecutive patients (from 2/2010 to 1/2013) with estrogen receptor (ER)-positive/HER2neu-negative invasive breast cancer who had the 21-gene recurrence score (RS) test (Oncotype DX, Genomic Health).

Field Strength/Sequence: Each subject underwent presurgical 3T breast MRI, which included DWI (b = 0, 800 s/mm2 ).

Assessment: Apparent diffusion coefficient (ADC) and contrast-to-noise ratio (CNR) were measured for each lesion by a fifth year radiology resident. Pathological markers (Nottingham histologic grade, Ki-67, RS) were determined from pathology reports. Medical records were reviewed to assess recurrence-free survival.

Statistical Tests: RS was stratified into low (<18), moderate (18-30), and high (>30)-risk groups. Associations of DWI characteristics with pathologic biomarkers were evaluated by binary or ordinal logistic regression, as appropriate, with adjustment for multiple comparisons. Post-hoc comparisons between specific groups were also performed.

Results: ADCmean (odds ratio [OR] = 0.61 per 1 standard deviation [SD] increase, adj. P = 0.044) and CNR (OR = 1.76 per 1-SD increase, adj. P = 0.026) were significantly associated with increasing tumor grade. DWI CNR was also significantly associated with a high (Ki-67 ≥14%) proliferation rate (OR = 2.55 per 1-SD increase, adj. P = 0.026). While there were no statistically significant linear associations in ADC (adj. P = 0.80-0.85) and CNR (adj. P = 0.56) across all three RS groups by ordinal logistic regression, post-hoc analyses suggested that high RS lesions exhibited lower ADCmean (P = 0.037) and ADCmax (P = 0.004) values and higher CNR (P = 0.008) compared to lesions with a low or moderate RS.

Data Conclusion: DWI characteristics correlated with tumor grade, proliferation index, and RS, and may potentially help to identify those with highest recurrence risk and most potential benefit from chemotherapy.

Level Of Evidence: 3 Technical Efficacy Stage 3 J. Magn. Reson. Imaging 2017.

Keywords: Oncotype DX 21-gene recurrence score; adjuvant chemotherapy; breast cancer; diffusion-weighted imaging (DWI); prognostic biomarker.

Diffusion-weighted MRI: association between patient characteristics and apparent diffusion coefficients of normal breast fibroglandular tissue at 3 T.
Elizabeth S McDonald, Jennifer G Schopp, +5 authors, Savannah C Partridge.
AJR Am J Roentgenol, 2014 Apr 25; 202(5). PMID: 24758685    Free PMC article.
Breast cancer subtype intertumor heterogeneity: MRI-based features predict results of a genomic assay.
Elizabeth J Sutton, Jung Hun Oh, +5 authors, Elizabeth A Morris.
J Magn Reson Imaging, 2015 Apr 09; 42(5). PMID: 25850931    Free PMC article.
Highly Cited.
A Radio-genomics Approach for Identifying High Risk Estrogen Receptor-positive Breast Cancers on DCE-MRI: Preliminary Results in Predicting OncotypeDX Risk Scores.
Tao Wan, B Nicolas Bloch, +5 authors, Anant Madabhushi.
Sci Rep, 2016 Feb 19; 6. PMID: 26887643    Free PMC article.
Prediction of risk of distant recurrence using the 21-gene recurrence score in node-negative and node-positive postmenopausal patients with breast cancer treated with anastrozole or tamoxifen: a TransATAC study.
Mitch Dowsett, Jack Cuzick, +11 authors, Steven Shak.
J Clin Oncol, 2010 Mar 10; 28(11). PMID: 20212256
Highly Cited.
Diffusion-weighted imaging in breast cancer: relationship between apparent diffusion coefficient and tumour aggressiveness.
M Costantini, P Belli, +5 authors, L Bonomo.
Clin Radiol, 2010 Nov 13; 65(12). PMID: 21070905
Prediction of Low versus High Recurrence Scores in Estrogen Receptor-Positive, Lymph Node-Negative Invasive Breast Cancer on the Basis of Radiologic-Pathologic Features: Comparison with Oncotype DX Test Recurrence Scores.
Vandana Dialani, Shantanu Gaur, +5 authors, Priscilla J Slanetz.
Radiology, 2016 Mar 05; 280(2). PMID: 26937802
Histogram analysis of apparent diffusion coefficient at 3.0t: Correlation with prognostic factors and subtypes of invasive ductal carcinoma.
Eun Jeong Kim, Sung Hun Kim, +8 authors, Robert Grimm.
J Magn Reson Imaging, 2015 Apr 29; 42(6). PMID: 25919239
Diffusion-Weighted Breast Magnetic Resonance Imaging: A Semiautomated Voxel Selection Technique Improves Interreader Reproducibility of Apparent Diffusion Coefficient Measurements.
Habib Rahbar, Brenda F Kurland, +6 authors, Savannah C Partridge.
J Comput Assist Tomogr, 2016 May 19; 40(3). PMID: 27192501    Free PMC article.
American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer.
Lyndsay Harris, Herbert Fritsche, +7 authors, American Society of Clinical Oncology.
J Clin Oncol, 2007 Oct 24; 25(33). PMID: 17954709
Highly Cited. Review.
Correlation of the apparent diffusion coefficiency values on diffusion-weighted imaging with prognostic factors for breast cancer.
S Y Choi, Y-W Chang, +3 authors, D Y Seo.
Br J Radiol, 2011 Dec 01; 85(1016). PMID: 22128125    Free PMC article.
Diffusion-weighted breast MRI: Clinical applications and emerging techniques.
Savannah C Partridge, Noam Nissan, +2 authors, Eric E Sigmund.
J Magn Reson Imaging, 2016 Oct 01; 45(2). PMID: 27690173    Free PMC article.
Highly Cited. Review.
Why does Oncotype DX recurrence score reduce adjuvant chemotherapy use?
Jeffrey G Schneider, Danny N Khalil.
Breast Cancer Res Treat, 2012 Jun 23; 134(3). PMID: 22723033    Free PMC article.
Gene expression profiles in paraffin-embedded core biopsy tissue predict response to chemotherapy in women with locally advanced breast cancer.
Luca Gianni, Milvia Zambetti, +14 authors, Steven Shak.
J Clin Oncol, 2005 Sep 08; 23(29). PMID: 16145055
Highly Cited.
Correlation of the SUVmax of FDG-PET and ADC values of diffusion-weighted MR imaging with pathologic prognostic factors in breast carcinoma.
Kazuhiro Kitajima, Toshiko Yamano, +7 authors, Shozo Hirota.
Eur J Radiol, 2016 May 01; 85(5). PMID: 27130054
Tamoxifen and chemotherapy for lymph node-negative, estrogen receptor-positive breast cancer.
B Fisher, J Dignam, +10 authors, R G Margolese.
J Natl Cancer Inst, 1997 Dec 09; 89(22). PMID: 9390536
Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer.
Soonmyung Paik, Gong Tang, +11 authors, Norman Wolmark.
J Clin Oncol, 2006 May 25; 24(23). PMID: 16720680
Highly Cited.
A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer.
Soonmyung Paik, Steven Shak, +12 authors, Norman Wolmark.
N Engl J Med, 2004 Dec 14; 351(27). PMID: 15591335
Highly Cited.
Correlation of the apparent diffusion coefficient value and dynamic magnetic resonance imaging findings with prognostic factors in invasive ductal carcinoma.
Su Kyung Jeh, Sung Hun Kim, +4 authors, Byung Joo Song.
J Magn Reson Imaging, 2010 Dec 25; 33(1). PMID: 21182127
MR Imaging Radiomics Signatures for Predicting the Risk of Breast Cancer Recurrence as Given by Research Versions of MammaPrint, Oncotype DX, and PAM50 Gene Assays.
Hui Li, Yitan Zhu, +13 authors, Maryellen L Giger.
Radiology, 2016 Oct 19; 281(2). PMID: 27144536    Free PMC article.
Highly Cited.
Identification of intrinsic imaging phenotypes for breast cancer tumors: preliminary associations with gene expression profiles.
Ahmed Bilal Ashraf, Dania Daye, +4 authors, Despina Kontos.
Radiology, 2014 Apr 08; 272(2). PMID: 24702725    Free PMC article.
High-resolution diffusion-weighted imaging for the separation of benign from malignant BI-RADS 4/5 lesions found on breast MRI at 3T.
Dorota J Wisner, Nathan Rogers, +6 authors, Nola M Hylton.
J Magn Reson Imaging, 2013 Nov 12; 40(3). PMID: 24214467    Free PMC article.
Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer.
Maggie C U Cheang, Stephen K Chia, +10 authors, Torsten O Nielsen.
J Natl Cancer Inst, 2009 May 14; 101(10). PMID: 19436038    Free PMC article.
Highly Cited.
Long term side effects of adjuvant chemotherapy in patients with early breast cancer.
Jessica J Tao, Kala Visvanathan, Antonio C Wolff.
Breast, 2015 Aug 25; 24 Suppl 2. PMID: 26299406    Free PMC article.
Review.
Evaluating use characteristics for the oncotype dx 21-gene recurrence score and concordance with chemotherapy use in early-stage breast cancer.
Clara Chen, Rahul Dhanda, +2 authors, Debra A Patt.
J Oncol Pract, 2013 Aug 15; 9(4). PMID: 23942918    Free PMC article.
West German Study Group Phase III PlanB Trial: First Prospective Outcome Data for the 21-Gene Recurrence Score Assay and Concordance of Prognostic Markers by Central and Local Pathology Assessment.
Oleg Gluz, Ulrike A Nitz, +18 authors, Nadia Harbeck.
J Clin Oncol, 2016 Mar 02; 34(20). PMID: 26926676
Highly Cited.
Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial.
Kathy S Albain, William E Barlow, +20 authors, Breast Cancer Intergroup of North America.
Lancet Oncol, 2009 Dec 17; 11(1). PMID: 20005174    Free PMC article.
Highly Cited.
Luminal-type breast cancer: correlation of apparent diffusion coefficients with the Ki-67 labeling index.
Naoko Mori, Hideki Ota, +7 authors, Shoki Takahashi.
Radiology, 2014 Sep 10; 274(1). PMID: 25203132
Dynamic contrast-enhanced and diffusion-weighted MRI of estrogen receptor-positive invasive breast cancers: Associations between quantitative MR parameters and Ki-67 proliferation status.
Jong Ki Shin, Jin You Kim.
J Magn Reson Imaging, 2016 Jun 18; 45(1). PMID: 27313102
In vivo assessment of ductal carcinoma in situ grade: a model incorporating dynamic contrast-enhanced and diffusion-weighted breast MR imaging parameters.
Habib Rahbar, Savannah C Partridge, +4 authors, Constance D Lehman.
Radiology, 2012 Apr 21; 263(2). PMID: 22517955    Free PMC article.
Prospective Validation of a 21-Gene Expression Assay in Breast Cancer.
Joseph A Sparano, Robert J Gray, +28 authors, George W Sledge.
N Engl J Med, 2015 Sep 29; 373(21). PMID: 26412349    Free PMC article.
Highly Cited.
NCCN Task Force report: Evaluating the clinical utility of tumor markers in oncology.
Phillip G Febbo, Marc Ladanyi, +10 authors, Marian L Birkeland.
J Natl Compr Canc Netw, 2011 Dec 22; 9 Suppl 5. PMID: 22138009
Highly Cited.
Apparent diffusion coefficient in estrogen receptor-positive and lymph node-negative invasive breast cancers at 3.0T DW-MRI: A potential predictor for an oncotype Dx test recurrence score.
Sunitha B Thakur, Manuela Durando, +5 authors, Elizabeth A Morris.
J Magn Reson Imaging, 2017 Jun 24; 47(2). PMID: 28640531    Free PMC article.
Correlation between 3T apparent diffusion coefficient values and grading of invasive breast carcinoma.
Valentina Cipolla, Domiziana Santucci, +3 authors, Carlo de Felice.
Eur J Radiol, 2014 Oct 12; 83(12). PMID: 25305145
Distinguishing luminal breast cancer subtypes by Ki67, progesterone receptor or TP53 status provides prognostic information.
Linda P Feeley, Anna M Mulligan, +2 authors, Irene L Andrulis.
Mod Pathol, 2013 Sep 21; 27(4). PMID: 24051696
Diffusion-weighted imaging: Effects of intravascular contrast agents on apparent diffusion coefficient measures of breast malignancies at 3 Tesla.
Vicky T Nguyen, Habib Rahbar, +3 authors, Savannah C Partridge.
J Magn Reson Imaging, 2015 Jan 23; 42(3). PMID: 25611726    Free PMC article.
Role of DCE-MR in predicting breast cancer subtypes.
Marco Macchini, Martina Ponziani, +4 authors, Gian Marco Giuseppetti.
Radiol Med, 2018 Jun 06; 123(10). PMID: 29869226
Can diffusion-weighted imaging predict tumor grade and expression of Ki-67 in breast cancer? A multicenter analysis.
Alexey Surov, Paola Clauser, +6 authors, Andreas Wienke.
Breast Cancer Res, 2018 Jun 21; 20(1). PMID: 29921323    Free PMC article.
Application of Radiomics and Decision Support Systems for Breast MR Differential Diagnosis.
Ioannis Tsougos, Alexandros Vamvakas, +2 authors, Katerina Vassiou.
Comput Math Methods Med, 2018 Oct 23; 2018. PMID: 30344618    Free PMC article.
Review.
Diffusion-weighted MRI of estrogen receptor-positive, HER2-negative, node-negative breast cancer: association between intratumoral heterogeneity and recurrence risk.
Jin You Kim, Jin Joo Kim, +8 authors, Robert Grimm.
Eur Radiol, 2019 Aug 07; 30(1). PMID: 31385051
Apparent diffusion coefficient cannot predict molecular subtype and lymph node metastases in invasive breast cancer: a multicenter analysis.
Alexey Surov, Yun-Woo Chang, +4 authors, Andreas Wienke.
BMC Cancer, 2019 Nov 07; 19(1). PMID: 31690273    Free PMC article.
Radiomic analysis of imaging heterogeneity in tumours and the surrounding parenchyma based on unsupervised decomposition of DCE-MRI for predicting molecular subtypes of breast cancer.
Ming Fan, Peng Zhang, +5 authors, Lihua Li.
Eur Radiol, 2019 Jan 09; 29(8). PMID: 30617495
Diffusion-weighted imaging of the breast: current status as an imaging biomarker and future role.
Julia Camps-Herrero.
BJR Open, 2019 Mar 08; 1(1). PMID: 33178933    Free PMC article.
Review.
Quantitative parameters of MRI and 18F-FDG PET/CT in the prediction of breast cancer prognosis and molecular type: an original study.
Pavel Borisovich Gelezhe, Ivan Andreevich Blokhin, Damir Ildarovich Marapov, Sergey Pavlovich Morozov.
Am J Nucl Med Mol Imaging, 2020 Dec 18; 10(6). PMID: 33329930    Free PMC article.